Volume 56, Pages S15-S19 (November 1999)

Slides:



Advertisements
Similar presentations
Renal involvement in hepatitis C infection: Cryoglobulinemic glomerulonephritis Giuseppe D’Amico Kidney International Volume 54, Issue 2, Pages
Advertisements

Renal Stress Testing in the Assessment of Kidney Disease Lakhmir S. Chawla, Claudio Ronco Kidney International Reports Volume 1, Issue 1, Pages (May.
Pathophysiology of renal fluid retention
Erythropoietin should be part of congestive heart failure management
Hemodialyzer: From macro-design to membrane nanostructure; the case of the FX- class of hemodialyzers  Claudio Ronco, Sudhir Kumar Bowry, Alessandra Brendolan,
Erythropoietin should be part of congestive heart failure management
Volume 56, Pages S95-S98 (November 1999)
Regional citrate versus systemic heparin anticoagulation for continuous renal replacement in critically ill patients  Demetrios J. Kutsogiannis, R.T.Noel.
Volume 54, Issue 3, Pages (September 1998)
Obesity, inflammation, and kidney disease
Macrophage heterogeneity, phenotypes, and roles in renal fibrosis
Zaccaria Ricci, Claudio Ronco, Sergio Picardo  Kidney International 
Volume 68, Issue 5, Pages (November 2005)
Volume 60, Issue 2, Pages (August 2001)
Continuous renal replacement therapy in the critically ill patient
Progression of renal failure and hypertensive nephrosclerosis
Section 5: Dialysis Interventions for Treatment of AKI
Pathophysiology of renal fluid retention
Francesco Paolo Schena  Kidney International 
Volume 70, Pages S21-S25 (December 2006)
Effects of a reduced inner diameter of hollow fibers in hemodialyzers
Pasquale Esposito, Teresa Rampino, Giuseppe Sileno, Antonio Dal Canton 
George A. Kaysen, Burl R. Don
A new era in phosphate binder therapy: What are the options?
D. Coyne  Kidney International  Volume 69, Pages S1-S3 (May 2006)
Immunoglobulin light chains in uremia
James D. House, Margaret E. Brosnan, John T. Brosnan 
Effects of a reduced inner diameter of hollow fibers in hemodialyzers
Volume 76, Issue 6, Pages (September 2009)
Volume 70, Issue 7, Pages (October 2006)
Extracorporeal therapy in sepsis: are we there yet?
405. Hindlimb and Forelimb Strength Assessment in a Canine Model of X-Linked Myotubular Myopathy Following AAV-Mediated Gene Replacement    Molecular.
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Volume 63, Pages S38-S42 (February 2003)
Microbiology and outcomes of peritonitis in North America
Nephrology in Latin America, with special emphasis on Brazil
Methods for guideline development
AGEs in foods: Do they play a role in uremia?
Randomized long-term evaluation of bicarbonate-buffered CAPD solution
Lynda Anne Szczech, Ira L. Lazar  Kidney International 
Hemodiafiltration with online regeneration of the ultrafiltrate
Joachim Böhler, M.D., Johannes Donauer, Frieder Keller 
Volume 82, Issue 9, Pages (November 2012)
Volume 54, Issue 5, Pages (November 1998)
Volume 60, Issue 4, Pages (October 2001)
Opportunities for a chronic disease outreach program in China
Peritoneal dialysis in Mexico
Taking a public health approach to the prevention of end-stage renal disease: The NKF Singapore Program  Sylvia Paz B. Ramirez, Stephen I-Hong Hsu, William.
Phosphate binders on iron basis: A new perspective?
Organ transplantation goes to the movies
Volume 56, Pages S71-S74 (November 1999)
Volume 55, Pages S3-S16 (June 1999)
Volume 58, Issue 2, Pages (August 2000)
Volume 56, Pages S84-S87 (November 1999)
Volume 80, Issue 10, Pages (November 2011)
Volume 80, Issue 10, Pages (November 2011)
Confounding factors in the assessment of delivered hemodialysis dose
Charles A. Herzog  Kidney International 
Volume 64, Pages S78-S86 (November 2003)
Is complement a target for therapy in renal disease?
Review of clinical trial experience with icodextrin
Renal replacement therapy in Latin America
Volume 58, Pages S148-S155 (August 2000)
Adiponectin: good, bad, or just plain ugly?
Strategies for iron supplementation: Oral versus intravenous
Tumor necrosis factor-α in cisplatin nephrotoxicity: A homebred foe?
Recombinant hirudin (lepirudin) as anticoagulant in intensive care patients treated with continuous hemodialysis  Karl-Georg Fischer, M.D., Andreas van.
Morphology of the heart and arteries in renal failure
Volume 74, Pages S4-S9 (December 2008)
Presentation transcript:

Volume 56, Pages S15-S19 (November 1999) Use of adsorptive mechanisms in continuous renal replacement therapies in the critically ill  Ciro Tetta, Rinaldo Bellomo, Alessandra Brendolan, Pasquale Piccinni, Antonio Digito, Maurizio Dan, Marco Irone, Gerhard Lonnemann, Donatella Moscato, Juan Buades, Giuseppe La Greca, Claudio Ronco  Kidney International  Volume 56, Pages S15-S19 (November 1999) DOI: 10.1046/j.1523-1755.56.s72.16.x Copyright © 1999 International Society of Nephrology Terms and Conditions

Figure 1 Criteria to assess the efficiency of plasma filtration versus ultrafiltration to study in vitro the adsorption of sepsis-associated mediators tumor necrosis factor-α (TNF-α), interlukin-1β (IL-1β), IL-8, and platelet activating factor (PAF). Symbols are: () % removed mass; () % drop in concentration; (▪) clearance. Kidney International 1999 56, S15-S19DOI: (10.1046/j.1523-1755.56.s72.16.x) Copyright © 1999 International Society of Nephrology Terms and Conditions

Figure 2 Plasma treatment in sepsis including the criteria to assess the efficiency of the sorbent. Kidney International 1999 56, S15-S19DOI: (10.1046/j.1523-1755.56.s72.16.x) Copyright © 1999 International Society of Nephrology Terms and Conditions

Figure 3 Development of plasma filtration coupled with sorbent adsorption (CPFA). Kidney International 1999 56, S15-S19DOI: (10.1046/j.1523-1755.56.s72.16.x) Copyright © 1999 International Society of Nephrology Terms and Conditions

Figure 4 Criteria used to assess the efficiency of innovative techniques to treat sepsis. Kidney International 1999 56, S15-S19DOI: (10.1046/j.1523-1755.56.s72.16.x) Copyright © 1999 International Society of Nephrology Terms and Conditions